# The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles

> **NCT03659864** · NA · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 26 (actual)

## Conditions studied

- Blood Biomarkers
- Vasodilation
- Blood Clotting
- Lung Function
- Healthy Volunteers

## Interventions

- **OTHER:** diesel exhaust particulate
- **OTHER:** carbon nanoparticles
- **OTHER:** small graphene oxide
- **OTHER:** ultrasmall graphene oxide
- **OTHER:** filtered air

## Key facts

- **NCT ID:** NCT03659864
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-03
- **Primary completion:** 2019-03-29
- **Final completion:** 2020-11-27
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03659864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03659864, "The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03659864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*